Dexmedetomidine Hydrochloride Injection 0.2?mg/2?mL ×?5 Vials (Lyophilized Powder) [For Laboratory Research Use Only]

Description Contents hide 1 Product Specifications 2 Mechanism of Action 3 Research Applications & Pharmacology 4 Safety Profile & Handling 4.1 ?? Research?Use Disclaimer Product SpecificationsAttributeDetailsProduct NameDexmedetomidine Hydrochloride InjectionGeneric NameDexmedetomidine hydrochlorideCAS Number113775?47?6 ringpu.com 7en.wikipedia.org 7go.drugbank.com 7Molecular FormulaC??H??N?·HClMolecular Weight~236.7?g/molDosage FormLyophilized powder for injectionStrength0.2?mg per 2?mL vialPack Size5 vials per boxApproval NumberH20203335 (NMPA)Product Code86902581000113ManufacturerSinopharm Group Langfang Co., Ltd.StorageStore at 2–8?°C, protect from lightIntended UseLaboratory research onlyMechanism of ActionDexmedetomidine is a highly selective ???adrenergic agonist (??:?? ?1620:1), producing sedation by decreasing noradrenergic activity in the locus ceruleus and providing analgesia via spinal pathways—without significant respiratory depression.Research Applications & PharmacologySedation & analgesia models: Commonly applied in rodent, canine, and feline models to induce calmness and reduce anxiety or pain pre-procedure .Dosage examples: IM 125–500?µg/m² or IV 375?µg/m² in dogs; IM 40?µg/kg in cats .Pharmacokinetics: High protein binding (~94%), 2–4?hr half-life; hepatic metabolism; excretion via urine.Safety Profile & HandlingObserved effects:Sedation, mild bradycardia or hypotension, transient respiratory depression in high doses .Avoid mixing with other sedatives to reduce overdose risks.Handling precautions:Reconstitute per instructions (e.g., to 4?µg/mL for IV infusion) .Use aseptic technique, monitor vitals, and properly dispose of vials as pharmaceutical waste.?? Research?Use DisclaimerThis product is intended solely for laboratory research. It is not approved for clinical, diagnostic, therapeutic, or veterinary use. Improper usage may compromise subject safety and data validity.